Announcing Planned Documentary on Postpartum Depression: More Than Blue
Interested in telling your story or know of others who wish to share their PPD journey? We seek those who may be interested in participating in the documentary in some capacity.
Sepranolone: A New Treatment for PMDD?
In this phase II study, sepranolone 10 mg administered subcutaneously during the late luteal phase reduced PMDD symptoms more than placebo.
Neurodevelopmental Disorders in Children Exposed to Antipsychotic Medications During Pregnancy
Prenatal exposure to antipsychotic medications was not associated with increased risk of neurodevelopmental disorders in offspring.
Weekly Roundup for APRIL 1, 2022: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
Can Intravenous Ketamine Reduce Risk for Postpartum Depression?
Intravenous ketamine at delivery reduced risk for postpartum depression; however, only in women at high risk for PPD.
Essential Reads: What is the Best Screening Tool for Depression During Pregnancy?
Many women experience depression during pregnancy. What is the best way to identify these women?